ClinVar Miner

Submissions for variant NM_005120.3(MED12):c.6150GCA[3] (p.Gln2074_Gln2076del)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV003596118 SCV003268431 benign FG syndrome 2023-11-07 criteria provided, single submitter clinical testing
Ambry Genetics RCV004632106 SCV005133855 uncertain significance Familial thoracic aortic aneurysm and aortic dissection 2024-05-23 criteria provided, single submitter clinical testing The c.6159_6167delGCAGCAGCA variant (also known as p.Q2074_Q2076del) is located in coding exon 42 of the MED12 gene. This variant results from an in-frame GCAGCAGCA deletion at nucleotide positions 6159 to 6167. This results in the in-frame deletion of a at codon 2074. These amino acid positions are highly conserved in available vertebrate species. In addition, this alteration is predicted to be neutral by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Based on data from gnomAD, this variant has an overall frequency of <0.01% (1/179513) total alleles studied, with 1 hemizygote(s) observed. The highest observed frequency was <0.01% (1/79541) of European (non-Finnish) alleles. Based on the available evidence, the clinical significance of this variant remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.